Tag: nicotinamide riboside
ChromaDex Receives Authorization for Niagen in EU, Australia
Los Angeles, CA—ChromaDex Corp. announced in a press release that it has received regulatory authorizations to sell its patented nicotinamide riboside chloride (branded Niagen)...
ChromaDex Initiates Study on NR, Aging
Los Angeles, CA—ChromaDex Corp announced in a press release the initiation of a first-of-its-kind Phase 1 clinical study sponsored by the University of Florida,...
Form of B3 Linked to Breastfeeding Benefits in Mice
Iowa City, IA--A new animal study from researchers at the University of Iowa found that giving nursing rodents a supplemental form of vitamin B3...
Alzheimer’s Disease Research Breakthrough
Irvine, CA — Research published in the journal Nature showed promise that nicotinamide riboside (NR) may help lower levels of amyloid deposits and improve...
